NovaBridge Biosciences (NBP) Invested Capital (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Invested Capital for 4 consecutive years, with $4.2 million the latest figure, recorded in Q4 2023.

• In Q4 2023, Invested Capital rose 56.17% year-over-year to $4.2 million; the TTM figure through Sep 2024 stood at $4.2 million (down 40.06% YoY), while the FY2023 annual figure was $4.2 million, up 59.11% from the prior year.
• Invested Capital slipped to $4.2 million in Q4 2023 per NBP's latest filing, from $4.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $7.1 million in Q4 2019 and bottomed at $2.7 million in Q4 2022.
• Historically, Invested Capital has averaged $4.6 million across 3 years, with a median of $4.2 million in 2023.
• Annual changes were most pronounced in 2019 — Invested Capital tumbled 38.69% — and 2023, when it jumped 56.17%.
• NovaBridge Biosciences' Invested Capital stood at $7.1 million in 2019, then plunged by 62.43% to $2.7 million in 2022, then surged by 56.17% to $4.2 million in 2023.
• Business Quant data shows NBP's Invested Capital at $4.2 million in Q4 2023, $4.3 million in Q2 2023, and $2.7 million in Q4 2022.